Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus
- 22 May 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 28 (3) , 260-261
- https://doi.org/10.1046/j.1365-2230.2003.01213.x
Abstract
Summary Imiquimod, an imidazoquinoline amine, is approved for the topical treatment of external anogenital warts induced by human papilloma virus. Several clinical trials have shown imiquimod to be a...Keywords
This publication has 7 references indexed in Scilit:
- Self‐administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosumBritish Journal of Dermatology, 2000
- Potentiating Effect of Imiquimod in the Treatment of Verrucae Vulgares in Immunocompromised PatientsPublished by Medical Journals Sweden AB ,2000
- Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virusActa Dermato-Venereologica, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Treatment of genital warts with an immune-response modifier (imiquimod)Published by Elsevier ,1998
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998